These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 6427461
1. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis. Mochan E, Uhl J. J Rheumatol; 1984 Apr; 11(2):123-8. PubMed ID: 6427461 [Abstract] [Full Text] [Related]
2. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis]. Gotoh H, Yamada H, Yoshihara Y, Kikuchi T, Obata K, Shinmei M. Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417 [Abstract] [Full Text] [Related]
3. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC. Thromb Haemost; 1992 Aug 03; 68(2):180-4. PubMed ID: 1412164 [Abstract] [Full Text] [Related]
4. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J. Br J Rheumatol; 1992 Aug 03; 31 Suppl 1():19-26. PubMed ID: 1555050 [Abstract] [Full Text] [Related]
5. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee. Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH. J Rheumatol; 2006 Feb 03; 33(2):311-7. PubMed ID: 16465663 [Abstract] [Full Text] [Related]
6. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. Saxne T, Lecander I, Geborek P. J Rheumatol; 1993 Jan 03; 20(1):91-6. PubMed ID: 8441174 [Abstract] [Full Text] [Related]
7. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis. Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S. J Rheumatol; 2000 Apr 03; 27(4):997-1004. PubMed ID: 10782829 [Abstract] [Full Text] [Related]
8. Plasminogen activator in synovial fluid from patients with rheumatoid arthritis. Kikuchi H, Tanaka S, Matsuo O. J Rheumatol; 1987 Jun 03; 14(3):439-45. PubMed ID: 3625626 [Abstract] [Full Text] [Related]
9. Plasminogen activators in synovial fluid and plasma from patients with arthritis. Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC. Ann Rheum Dis; 1992 Aug 03; 51(8):965-8. PubMed ID: 1417121 [Abstract] [Full Text] [Related]
10. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Belcher C, Fawthrop F, Bunning R, Doherty M. Ann Rheum Dis; 1996 Apr 03; 55(4):230-6. PubMed ID: 8733439 [Abstract] [Full Text] [Related]
11. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F. J Rheumatol; 1993 Apr 03; 20(4):714-7. PubMed ID: 7684449 [Abstract] [Full Text] [Related]
12. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O. Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412 [Abstract] [Full Text] [Related]
13. Clinical correlation with the PA/plasmin system in septic arthritis of the knee. Hsieh YS, Yang SF, Lue KH, Lu KH. Clin Orthop Relat Res; 2006 Jun 15; 447():172-8. PubMed ID: 16505706 [Abstract] [Full Text] [Related]
14. RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Stanczyk J, Kowalski ML, Grzegorczyk J, Szkudlinska B, Jarzebska M, Marciniak M, Synder M. Mediators Inflamm; 2005 Dec 14; 2005(6):343-8. PubMed ID: 16489254 [Abstract] [Full Text] [Related]
15. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Ronday HK, Smits HH, Van Muijen GN, Pruszczynski MS, Dolhain RJ, Van Langelaan EJ, Breedveld FC, Verheijen JH. Br J Rheumatol; 1996 May 14; 35(5):416-23. PubMed ID: 8646430 [Abstract] [Full Text] [Related]
16. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis. Blaschke S, Schulz H, Schwarz G, Blaschke V, Müller GA, Reuss-Borst M. J Rheumatol; 2001 Jan 14; 28(1):12-21. PubMed ID: 11196512 [Abstract] [Full Text] [Related]
17. Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. Cerinic MM, Generini S, Partsch G, Pignone A, Dini G, Konttinen YT, Del Rosso M. Life Sci; 1998 Jan 14; 63(6):441-53. PubMed ID: 9718068 [Abstract] [Full Text] [Related]
18. Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis. Furumitsu Y, Inaba M, Yukioka K, Yukioka M, Kumeda Y, Azuma Y, Ohta T, Ochi T, Nishizawa Y, Morii H. J Rheumatol; 2000 Jan 14; 27(1):64-70. PubMed ID: 10648019 [Abstract] [Full Text] [Related]
19. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Khan F, Siddiqui AA. Clin Chim Acta; 2006 Aug 14; 370(1-2):100-7. PubMed ID: 16513103 [Abstract] [Full Text] [Related]
20. [Detection and significance of plasminogen activator inhibitor in synovial tissue, synovial fluid and plasma from patients with rheumatoid arthritis]. Yang C, Huang F. Zhonghua Nei Ke Za Zhi; 2000 Oct 14; 39(10):690-3. PubMed ID: 11374178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]